XPLOSION+™ Eluting Coronary Stent system

XPLOSION+™ Eluting Coronary Stent system is the latest in the second generation of drug eluting stents, an ultimate combination of three outstanding elements: a clinically proven drug - Sirolimus, a modified Cobalt Chromium stent platform, and an excellent bioabsorbable drug carrier.

XPLOSION+™ takes the ideal definition of Safety - Efficiency - Deliverability for Percutaneous Coronary Intervention (PCI) to a higher level, convinces with its trusted technology and largest size portfolio available provides high end performance with less metallic coverage but reliable outcomes, and offers an optimal solution for improving luminal diameter and reducing in-stent restenosis when treating coronary artery lesions.

Abluminus DES Cobalt Chromium Coronar Sirolimus Eluting Stent

Abluminus DES is a Cobalt Chromium Stent System specially designed for diabetic patients. It is an abluminally coated sirolimus drug eluting stent. The drug is coated on both the stent and the exposed parts of the balloon. The stent system is coated on the abluminal side only, leading to directional drug release and less systemic exposure of drug. In current DES, coating on both the sides of the stent system, leads to slower rate of re-endothelialization.

The stent as well as the exposed parts of the balloon is coated with Sirolimus drug which provides DES+DEB effect. Diabetic patients suffer from diffuse proliferative disease which is longer in length. The fusion coating on entire stent system helps to address
the entire diseased area of the lesion.